| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2500272 | 注射用LY4101174 | LY4101174 | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-08 | Lilly Suzhou Pharmaceutical Co Ltd | view |